“…K13 protein was originally believed to protect virally infected cells from death receptor-induced apoptosis by preventing the activation of caspase-8 and, as such, was classified as a viral Fas-associated death domain protein-like IL-1b-converting enzyme inhibitory protein (vFLIP) (Bertin et al, 1997;Hu et al, 1997;Thome et al, 1997). However, we have subsequently shown that K13 is a strong inducer of the NF-kB pathway through the activation of the IkB kinase complex and does not function as a caspase-8 inhibitor (Chaudhary et al, 1999;Liu et al, 2002;Matta et al, 2003;Matta and Chaudhary, 2004;Chugh et al, 2005). We and others have further shown that K13 utilizes the NF-kB pathway to promote cellular transformation, cytokine secretion and protection against growth-factor withdrawal-induced apoptosis Sun et al, 2003aSun et al, , b, 2006.…”